• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O55多糖是用于制备抗O55肠出血性大肠杆菌和包膜性肠致病性大肠杆菌菌株疫苗的良好抗原靶点。

O55 Polysaccharides Are Good Antigen Targets for the Formulation of Vaccines against O55 STEC and Capsulated aEPEC Strains.

作者信息

Silva Herbert Guimarães de Sousa, Franzolin Marcia Regina, Anjos Geovana Ferreira Dos, Barbosa Angela Silva, Santos Luis Fernando Dos, Miranda Kaique Ferrari, Marques Ronaldo Maciel, Souza Matilde Costa Lima de, Piazza Roxane Maria Fontes, Domingos Marta de Oliveira

机构信息

Laboratório de Bacteriologia, Instituto Butantan, Avenida Vital Brasil, 1500, São Paulo CEP 05503-900, SP, Brazil.

Centro de Bacteriologia, Núcleo de Doenças Entéricas, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 355, São Paulo CEP 01246-000, SP, Brazil.

出版信息

Pathogens. 2022 Aug 9;11(8):895. doi: 10.3390/pathogens11080895.

DOI:10.3390/pathogens11080895
PMID:36015015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9414270/
Abstract

The serogroup O55 of is composed of strains whose mechanisms of virulence are different from each other. Since the O55 polysaccharides are present in all O55 strains, and so are the polymers that compose the capsule of O55 atypical enteropathogenic (aEPEC), it was investigated whether anti-O55 antibodies were able to help the innate immune system to eliminate capsulated aEPEC and Shiga toxin-producing (STEC) belonging to the serogroup O55. The results demonstrate that the capsule of EPEC was able to inhibit the deposition of C3b on the bacterial surface and, as a consequence, their lysis by the alternative pathway of the complement system. However, in the presence of antibodies, the ability of the complement to lyse these pathogens was restored. It was also observed that macrophages were able to ingest EPEC and STEC, but they were only able to kill the ingested pathogens in the presence of antibodies. Anti-O55 antibodies were also able to inhibit aEPEC and STEC O55 adherence to human epithelial cells. In summary, the results demonstrated that the O55 polysaccharides have the potential to induce an effective humoral immune response against STEC and EPEC, indicating that they are good antigen targets to be used in vaccine formulations against these pathogens.

摘要

O55血清群由毒力机制彼此不同的菌株组成。由于O55多糖存在于所有O55菌株中,构成O55非典型肠致病性大肠杆菌(aEPEC)荚膜的聚合物也是如此,因此研究了抗O55抗体是否能够帮助先天免疫系统清除属于O55血清群的有荚膜aEPEC和产志贺毒素大肠杆菌(STEC)。结果表明,EPEC的荚膜能够抑制C3b在细菌表面的沉积,因此,补体系统的替代途径无法使其裂解。然而,在有抗体存在的情况下,补体裂解这些病原体的能力得以恢复。还观察到巨噬细胞能够摄取EPEC和STEC,但只有在有抗体存在时它们才能杀死摄取的病原体。抗O55抗体也能够抑制aEPEC和STEC O55对人上皮细胞的黏附。总之,结果表明O55多糖有潜力诱导针对STEC和EPEC的有效体液免疫反应,这表明它们是用于针对这些病原体的疫苗制剂的良好抗原靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/50154dbab7ce/pathogens-11-00895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/a67495930cc3/pathogens-11-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/1532ad3c8c3c/pathogens-11-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/719c8d3340c8/pathogens-11-00895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/f3d25ab77421/pathogens-11-00895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/6a450876b8aa/pathogens-11-00895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/50154dbab7ce/pathogens-11-00895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/a67495930cc3/pathogens-11-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/1532ad3c8c3c/pathogens-11-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/719c8d3340c8/pathogens-11-00895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/f3d25ab77421/pathogens-11-00895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/6a450876b8aa/pathogens-11-00895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a211/9414270/50154dbab7ce/pathogens-11-00895-g006.jpg

相似文献

1
O55 Polysaccharides Are Good Antigen Targets for the Formulation of Vaccines against O55 STEC and Capsulated aEPEC Strains.O55多糖是用于制备抗O55肠出血性大肠杆菌和包膜性肠致病性大肠杆菌菌株疫苗的良好抗原靶点。
Pathogens. 2022 Aug 9;11(8):895. doi: 10.3390/pathogens11080895.
2
O26 Polysaccharides as Key Players in Enteropathogenic Immune Evasion and Vaccine Development.O26多糖在肠道致病菌免疫逃逸及疫苗研发中的关键作用
Int J Mol Sci. 2024 Mar 1;25(5):2878. doi: 10.3390/ijms25052878.
3
Characterisation of atypical enteropathogenic E. coli strains of clinical origin.临床来源的非典型肠致病性大肠杆菌菌株的特征分析。
BMC Microbiol. 2009 Jun 3;9:117. doi: 10.1186/1471-2180-9-117.
4
Genetic characterization of Shiga toxin-producing Escherichia coli (STEC) and atypical enteropathogenic Escherichia coli (EPEC) isolates from goat's milk and goat farm environment.来自山羊奶和山羊养殖场环境的产志贺毒素大肠杆菌(STEC)和非典型肠致病性大肠杆菌(EPEC)分离株的基因特征分析。
Int J Food Microbiol. 2016 Nov 7;236:148-54. doi: 10.1016/j.ijfoodmicro.2016.07.035. Epub 2016 Jul 30.
5
A sensitive method for the recovery of Escherichia coli serogroup O55 including Shiga toxin-producing variants for potential use in outbreaks.一种敏感的方法,用于回收包括产志贺毒素变异株在内的大肠杆菌 O55 血清群,以便在疫情爆发时使用。
J Appl Microbiol. 2019 Sep;127(3):889-896. doi: 10.1111/jam.14345. Epub 2019 Jul 7.
6
Detection of Shiga toxigenic (STEC) and enteropathogenic (EPEC) Escherichia coli in dairy buffalo.检测乳用型水牛中的产志贺毒素(STEC)和肠致病性(EPEC)大肠杆菌。
Vet Microbiol. 2014 May 14;170(1-2):162-6. doi: 10.1016/j.vetmic.2014.01.023. Epub 2014 Feb 3.
7
A universal polysaccharide conjugated vaccine against O111 E. coli.一种通用的 O111 大肠杆菌多糖共轭疫苗。
Hum Vaccin Immunother. 2014;10(10):2864-74. doi: 10.4161/21645515.2014.972145. Epub 2014 Nov 21.
8
Serotypes, virulence genes, and intimin types of Shiga toxin-producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC) isolated from calves in São Paulo, Brazil.从巴西圣保罗的犊牛中分离出的产志贺毒素大肠杆菌(STEC)和肠致病性大肠杆菌(EPEC)的血清型、毒力基因和紧密素类型。
Int J Food Microbiol. 2007 Apr 20;115(3):297-306. doi: 10.1016/j.ijfoodmicro.2006.10.046. Epub 2007 Jan 12.
9
Evolutionary Context of Non-Sorbitol-Fermenting Shiga Toxin-Producing Escherichia coli O55:H7.产志贺毒素非山梨醇发酵大肠埃希氏菌 O55:H7 的进化背景。
Emerg Infect Dis. 2017 Dec;23(12):1966-1973. doi: 10.3201/eid2312.170628.
10
Presence of Shiga toxin 2e-producing and atypical enteropathogenic in an asymptomatic child.一名无症状儿童体内存在产志贺毒素2e的菌株和非典型肠致病性菌株。
JMM Case Rep. 2014 Dec 1;1(4):e000001. doi: 10.1099/jmmcr.0.000001. eCollection 2014 Dec.

引用本文的文献

1
O26 Polysaccharides as Key Players in Enteropathogenic Immune Evasion and Vaccine Development.O26多糖在肠道致病菌免疫逃逸及疫苗研发中的关键作用
Int J Mol Sci. 2024 Mar 1;25(5):2878. doi: 10.3390/ijms25052878.

本文引用的文献

1
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.抗志贺毒素的治疗性抗体:趋势与展望。
Front Cell Infect Microbiol. 2022 Feb 10;12:825856. doi: 10.3389/fcimb.2022.825856. eCollection 2022.
2
Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina.阿根廷溶血性尿毒症综合征产志贺毒素大肠杆菌的流行病学及特征分析
Cureus. 2021 Aug 16;13(8):e17213. doi: 10.7759/cureus.17213. eCollection 2021 Aug.
3
Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing serotype O55:H7 in England, 2014-2018.
2014-2018 年在英国由产志贺毒素血清型 O55:H7 引起的溶血性尿毒综合征反复暴发的流行病学调查。
Epidemiol Infect. 2021 Apr 19;149:e108. doi: 10.1017/S0950268821000844.
4
Prevalence of Enteropathogens and Virulence Traits in Brazilian Children With and Without Diarrhea.巴西腹泻和未腹泻儿童肠道病原体及毒力特征的流行情况
Front Cell Infect Microbiol. 2020 Sep 25;10:549919. doi: 10.3389/fcimb.2020.549919. eCollection 2020.
5
The protective capacity of anti-O4 antigen antibodies against Salmonella infection is influenced by the presence or absence of the O5 antigen.抗 O4 抗原抗体对沙门氏菌感染的保护能力受 O5 抗原的存在与否影响。
Vaccine. 2020 Jul 22;38(34):5408-5412. doi: 10.1016/j.vaccine.2020.06.054. Epub 2020 Jun 30.
6
Phagocytosis: Our Current Understanding of a Universal Biological Process.吞噬作用:对普遍生物学过程的现有理解。
Front Immunol. 2020 Jun 2;11:1066. doi: 10.3389/fimmu.2020.01066. eCollection 2020.
7
Escherichia coli O-antigen capsule (group 4) is essential for serum resistance.大肠杆菌O抗原荚膜(4组)对血清抗性至关重要。
Res Microbiol. 2020 Mar;171(2):99-101. doi: 10.1016/j.resmic.2019.12.002. Epub 2020 Jan 24.
8
Structure and genetics of Escherichia coli O antigens.大肠杆菌 O 抗原的结构与遗传学。
FEMS Microbiol Rev. 2020 Nov 24;44(6):655-683. doi: 10.1093/femsre/fuz028.
9
Development and Validation of Shiga Toxin-Producing Immunodiagnostic Assay.产志贺毒素免疫诊断检测方法的开发与验证
Microorganisms. 2019 Aug 21;7(9):276. doi: 10.3390/microorganisms7090276.
10
New insights into the immune functions of complement.补体免疫功能的新见解。
Nat Rev Immunol. 2019 Aug;19(8):503-516. doi: 10.1038/s41577-019-0168-x.